Table 2. Pathological patterns of cancers on biopsies and markers (tPSA, f/tPSA, number of LOH).
| Age | tPSA | f/tPSA | Number of LOH | Gleason score from biopsy | Grade 1 | Grade 2 | Stage pTa from biopsy |
|---|---|---|---|---|---|---|---|
| 73 | 6 | 7 | 1 | 5 | 3 | 2 | 2a |
| 84 | 8 | 20 | 2 | 7 | 4 | 3 | 2b |
| 56 | 6 | 19 | 2 | 4 | 2 | 2 | 2a |
| 63 | 7 | 15 | 2 | 6 | 3 | 3 | 2a |
| 66 | 4 | 15 | 2 | 6 | 3 | 3 | 2a |
| 58 | 6 | 8 | 2 | 6 | 3 | 3 | 2a |
| 69 | 10 | 11 | 3 | 6 | 3 | 3 | 2b |
| 81 | 7 | 11 | 1 | 6 | 3 | 3 | 2a |
| 72 | 7 | 7 | 1 | 6 | 3 | 3 | 2a |
| 75 | 6 | 16 | 1 | 6 | 3 | 3 | 2a |
| 58 | 7 | 6 | 0 | 7 | 4 | 3 | 2b |
| 61 | 8 | 27 | 1 | 4 | 2 | 2 | 2a |
| 64 | 4 | 22 | 5 | 6 | 3 | 3 | 2a |
| 68 | 7 | 7 | 1 | 6 | 3 | 3 | 2b |
| 56 | 7 | 17 | 5 | 4 | 2 | 2 | 2a |
| 57 | 6 | 25 | 5 | 6 | 3 | 3 | 2a |
| 66 | 5 | 17 | 2 | 5 | 3 | 2 | 2a |
| 59 | 8 | 15 | 3 | 4 | 2 | 2 | 2a |
| 75 | 8 | 15 | 0 | 5 | 2 | 3 | 2b |
| 72 | 6 | 14 | 1 | 5 | 2 | 3 | 2a |
| 69 | 6 | 17 | 3 | 5 | 2 | 3 | 2a |
| 73 | 9 | 10 | 2 | 8 | 4 | 4 | 2a |
| 67 | 5 | 15 | 1 | 7 | 3 | 4 | 2b |
| 56 | 6 | 10 | 2 | 7 | 4 | 3 | 2b |
| 70 | 8 | 12 | 3 | 6 | 3 | 3 | 2a |
| 56 | 6 | 7 | 2 | 6 | 3 | 3 | 2a |
| 67 | 5 | 17 | 3 | 6 | 3 | 3 | 2a |
| 93 | 5 | 8 | 1 | 8 | 4 | 4 | 2b |
| 73 | 7 | 16 | 3 | 6 | 3 | 3 | 2a |
| 66 | 4 | 15 | 4 | 6 | 3 | 3 | 2a |
| 60 | 6 | 24 | 1 | 5 | 3 | 2 | 2a |
| 58 | 6 | 17 | 1 | 7 | 4 | 3 | 2b |
| 58 | 7 | 14 | 0 | 6 | 3 | 3 | 2a |
| 70 | 8 | 13 | 3 | 7 | 4 | 3 | 2c |
| 81 | 10 | 12 | 0 | 7 | 4 | 3 | 2c |
| 69 | 8 | 13 | 2 | 6 | 3 | 3 | 2c |
| 49 | 9 | 8 | 0 | 7 | 3 | 4 | 2c |
| 59 | 10 | 8 | 2 | 5 | 2 | 3 | 2c |
a
pT2a=Positive biopsies in one prostatic lobe, less than half-lobe, pT2b=positive biopsies in one prostatic lobe, more than half-lobe, pT2c=positive biopsies in the two prostatic lobes (according to UICC, TNM 2002).